[1]
“Immunogenicity of Hepavax-Gene recombinant hepatitis B vaccine in INML workers, Colombia”., Colomb Med, vol. 38, no. 4, pp. 375–381, Dec. 2007, doi: 10.25100/cm.v38i4.522.